Comparative study of cefaclor and amoxicillin in treatment of urinary tract infection
- PMID: 384643
- DOI: 10.1016/0090-4295(79)90489-8
Comparative study of cefaclor and amoxicillin in treatment of urinary tract infection
Abstract
Cefaclor or amoxicillin was given to 51 randomly assigned patients with urinary tract infections. Inclusion in the study required two pretreatment urine cultures yielding the same organism (susceptible to both antibiotics) in concentrations greater than or equal to 10(5)/ml. Both drugs were administered as 250 mg. orally every eight hours for ten days. Cefaclor was given to 27 patients and amoxicillin to 24. Most patients in both groups had negative urine cultures at five to nine days and four to six weeks following therapy. One patient in each group was unsuccessfully treated. Relapse or reinfection occurred with similar frequency in both treatment groups. Both antibiotics were well tolerated. minimal inhibiting concentrations (MICS) of cefaclor, amoxicillin, cephradine, and cephalexin were determined by an agar dilution technique for the 44 available pretreatment isolates (41 Escherichia coli and 3 Proteus mirabilis). Mean MICs (micrograms./ml., +/- SD) were 2.2 +/- 1.4 for cefaclor, 4.4 +/- 2.0 with amoxicillin, 8.1 +/- 4.2 for cephradine, and 5.7 +/- 3.0 with cephalexin. Cefaclor is highly active in vitro against those gram-negative bacteria which are commonly isolated from urine. Cefaclor is as effective as amoxicillin when administered three times daily for the treatment of urinary tract infection.
Similar articles
-
[Comparative study of cefaclor and amoxicillin in the treatment of urinary infections].Acta Urol Belg. 1981 Oct;49(4):447-51. Acta Urol Belg. 1981. PMID: 7325095 French. No abstract available.
-
Evaluation of cefaclor.Am J Hosp Pharm. 1981 Jan;38(1):54-8. Am J Hosp Pharm. 1981. PMID: 7011003 Review.
-
A comparison of cefaclor versus trimethoprim-sulfamethoxazole combination in the treatment of acute urinary infections.J Urol. 1981 Feb;125(2):228-9. doi: 10.1016/s0022-5347(17)54981-2. J Urol. 1981. PMID: 7009887 Clinical Trial.
-
Cefaclor in the treatment of skin, soft tissue, and urinary tract infections: a review.Clin Ther. 1988;11 Suppl A:71-82. Clin Ther. 1988. PMID: 3072089 Review. No abstract available.
-
[Comparative study of cefaclor versus amoxicillin in urinary tract infections (author's transl)].Infection. 1979;7 Suppl 6:617-21. doi: 10.1007/BF01659750. Infection. 1979. PMID: 399250 Clinical Trial. German.
Cited by
-
Cefaclor pharmacokinetic parameters: serum concentrations determined by a new high-performance liquid chromatographic technique.Antimicrob Agents Chemother. 1982 Jan;21(1):170-2. doi: 10.1128/AAC.21.1.170. Antimicrob Agents Chemother. 1982. PMID: 7081972 Free PMC article.
-
Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections.Antimicrob Agents Chemother. 1983 Nov;24(5):716-9. doi: 10.1128/AAC.24.5.716. Antimicrob Agents Chemother. 1983. PMID: 6362553 Free PMC article. Clinical Trial.
-
Loracarbef versus cefaclor in the treatment of urinary tract infections in women.Antimicrob Agents Chemother. 1991 Apr;35(4):750-2. doi: 10.1128/AAC.35.4.750. Antimicrob Agents Chemother. 1991. PMID: 2069382 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical